5,000
Participants
Start Date
October 31, 2013
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Forxiga
FORXIGA is a prescription medicine used with diet, exercise and sometimes other medicines (which may include metformin; insulin; a sulfonylurea medicine such as gliclazide, glimepiride and glibenclamide; or a dipeptidyl peptidase-4 inhibitor \[DPP 4 inhibitor\] such as sitagliptin or saxagliptin) to control the levels of blood sugar (glucose) in patients with type 2 diabetes mellitus.
Local Institution, Clayton
Lead Sponsor
Monash University
OTHER
AstraZeneca
INDUSTRY